Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Nanoscope Therapeutics
organization5 mentionslast seen Nov 5, 2026
Biotechnology company developing optogenetic gene therapies for retinal degeneration.
Relationships 10
- Nanoscope TherapeuticsemploysSamarendra Mohanty99% confidence5 sources
- Nanoscope TherapeuticsdevelopsMOGENRY99% confidence5 sources
- Nanoscope TherapeuticsemploysSulagna Bhattacharya99% confidence3 sources
- Nanoscope Therapeuticsdevelopsmulti-characteristic opsin99% confidence2 sources
- Nanoscope TherapeuticsemploysDamon Daulerio98% confidence1 source
- Nanoscope TherapeuticsemploysTroy Short98% confidence1 source
- Nanoscope TherapeuticsemploysSam Barone97% confidence1 source
- Nanoscope TherapeuticsemploysRamesh Arjunji97% confidence1 source
- Nanoscope TherapeuticsemploysPaul Hallen97% confidence1 source
- Nanoscope TherapeuticsemploysAnanta Ayagari90% confidence1 source
Relationship
Nanoscope Therapeuticsdevelopsmulti-characteristic opsin
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireNov 5, 2026Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs
Nanoscope's multi-characteristic opsin (MCO) technology
- newsPR NewswireOct 14, 2026Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
Nanoscope's multi-characteristic opsin (MCO) technology utilizes a proprietary genetically engineered synthetic opsin